Materials & Resources » Chemicals | Aceto Corp.

Aceto Corp. | Balance Sheet

Fiscal year is July-June. All values USD Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
35
44
37
68
58
Total Accounts Receivable
95
128
172
178
273
Inventories
84
101
96
98
136
Other Current Assets
4
4
5
7
4
Total Current Assets
218
276
310
350
472
Net Property, Plant & Equipment
11
12
10
10
10
Intangible Assets
74
154
147
147
522
Other Assets
11
14
12
13
15
Total Assets
323
468
490
538
1,038
ST Debt & Current Portion LT Debt
-
12
8
10
14
Accounts Payable
39
49
55
46
90
Income Tax Payable
-
-
6
-
2
Other Current Liabilities
39
55
60
51
118
Total Current Liabilities
90
119
125
99
223
Long-Term Debt
20
97
100
119
339
Provision for Risks & Charges
-
3
8
3
5
Deferred Taxes
8
12
10
9
12
Other Liabilities
19
16
2
6
59
Total Liabilities
129
234
236
236
633
Common Equity (Total)
195
234
254
302
405
Total Shareholders' Equity
195
234
254
302
405
Total Equity
195
234
254
302
405
Liabilities & Shareholders' Equity
323
468
490
538
1,038

About Aceto

View Profile
Address
4 Tri Harbor Court
Port Washington New York 11050
United States
Employees -
Website http://www.aceto.com
Updated 09/14/2018
Aceto Corp. engages in the development, marketing, sales, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products.